Patents
Literature
1 results about "Ephedrine" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Ephedrine is a medication and stimulant. It is often used to prevent low blood pressure during spinal anesthesia. It has also been used for asthma, narcolepsy, and obesity but is not the preferred treatment. It is of unclear benefit in nasal congestion. It can be taken by mouth or by injection into a muscle, vein, or just under the skin. Onset with intravenous use is fast, while injection into a muscle can take 20 minutes, and by mouth can take an hour for effect. When given by injection it lasts about an hour and when taken by mouth it can last up to four hours.
Application of ephedrine in the preparation of drugs for the prevention or treatment of peritoneal fibrosis
This invention discloses the application of ephedrine in the preparation of drugs for the prevention or treatment of peritoneal fibrosis, relating to the field of biomedical technology. The key technical point is: a pharmaceutical preparation for the prevention or treatment of peritoneal fibrosis, the active ingredient of which is ephedrine. This pharmaceutical preparation can achieve preventive and therapeutic effects on peritoneal fibrosis by inhibiting the mesothelial metastatic process (MMT) in peritoneal mesothelial cells, downregulating the expression of fibrosis-related proteins, and improving peritoneal ultrafiltration and solute transport functions, thus providing a new drug option for the treatment of end-stage renal disease patients undergoing peritoneal dialysis.
Owner:SHUNDE HOSPITAL SOUTHERN MEDICAL UNIV (THE FIRST PEOPLES HOSPITAL OF SHUNDE FOSHAN)